Therapeutic targeting of FLT3 and associated drug resistance in acute myeloid leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease caused by several gene mutations and cytogenetic abnormalities affecting differentiation and proliferation of myeloid lineage cells. FLT3 is a receptor t...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Melat T. Gebru and Hong-Gang Wang Tags: Review Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Genetics | Hematology | Leukemia